- The CHS-Shire Fellowship Program
- Multidisciplinary Collaboration
- Location of Tenure
- Stipend / Duration of Support
- General Conditions, Application Form and Deadlines
The CHS-Shire Fellowship Program
The Canadian Hemophilia Society - Shire Fellowship Program was created to engage hemophilia program professionals/graduate students from the disciplines of nursing, physiotherapy, social work and other related allied health disciplines in research focused on improving services and quality of life for people and families whose lives are affected by inherited bleeding disorders.
This program will offer one or more fellowships not exceeding total funding of $20,000. Please see the details provided below outlining the eligibility by discipline and ability to submit a multidisciplinary and/or multi centre application.
A candidate must be a Canadian citizen or permanent resident.
Applicants may send their proposals for any one of the following types of fellowships or a combination of these:
The objectives of the Nursing fellowship are to improve the delivery of care and expand the knowledge of nursing science surrounding bleeding disorders. The purpose of the Nursing Fellowship is to provide support for a registered nurse currently employed or interested in the field of inherited bleeding disorders to conduct nursing research or clinical projects. Only registered nurses from an accredited nursing school, enrolled in a graduate nursing program or practicing hemophilia nursing care may apply. This could include in-patient nurses who care for people with hemophilia as well as HTC nurses or infectious disease nurses.
Topics of interest include, but are not limited to, the unique considerations in the management and care of patients with inhibitors, the development of clinical pathways, measurable outcomes in inherited bleeding disorder care, service utilization, epidemiology and patient and community education tools. Other topics include rehabilitation, therapeutic modalities, psychosocial issues, women's health, liver disease in clients with bleeding disorders infected with HIV/AIDS or/and HCV.
The objectives of the Physical Therapy Fellowship are to improve the delivery of physical therapy care and expand the knowledge base specific to the management of the musculoskeletal effects of hemophilia. The Fellowship will provide support for a physical therapist currently employed or interested in the field of inherited bleeding disorders to conduct physical therapy research or clinical projects related to the care of the patient with hemophilia and other inherited bleeding disorders.
Topics of interest may include, but are not limited to, the following: the unique considerations in the management and care of patients with inhibitors, development of clinical pathways, physical therapy protocols, physical therapy utilization, measurable outcome studies, rehabilitation programs, use of modalities and other interventions commonly used by physical therapists in the treatment of the patient with hemophilia and other inherited bleeding disorders.
Social Work Fellowship
The objectives of the Social Work fellowship are to improve the delivery of care and expand the knowledge of psychosocial practices. The purpose of the Social Work fellowship is to provide support for a social worker currently employed or interested in the field of inherited bleeding disorders to conduct research or clinical projects related to the care of the patient with hemophilia and other bleeding disorders. To be eligible the applicant must be a MSW from an accredited school of social work or be a student in a PhD/DSW program. Professional experience in a hemophilia treatment centre is desirable but not required.
The proposed project must have relevance to current practice in bleeding disorder care and may incorporate casework, group work, organizational and public health, education and research perspectives. It is expected that the focus will be to: (1) promote the integration of psychosocial care with biomedical components of comprehensive care; (2) promote the delivery of quality services to patients and families; (3) contribute to the literature on the psychosocial aspects of bleeding disorders; (4) demonstrate social work outcomes of the research or clinical project.
Topics of interest may include, but are not limited to, the following: the unique considerations in the management and care of patients with inhibitors; impact of social work practice on coping with chronic illness and/or disability; impact of case management on patient care; improved clinical practice; research skills and goals for psychosocial providers; mental health issues of those affected with inherited bleeding disorders or bleeding disorders/HIV/HCV; development and use of media projects and/or learning tools for professional or patient evaluation. A focus on cultural diversity is welcomed.
Collaboration with multidisciplinary care providers and/or between two (2) or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. Inter-regional applications will also be considered. Note that, as stated above, although there may be more than one Fellowship awarded, total funding will not exceed $20,000. Please note that if a multidisciplinary project is sought, you are encouraged to indicate in the letter of intent and in the application how the project would proceed if only one Fellowship were to be awarded.
Location of Tenure
Fellowships are normally held at Canadian institutions but Canadian citizens can spend part of their Fellowship at institutions outside Canada, if the required nature or calibre of training is not available in Canada, with the agreement of their Canadian supervisor.
Fellows must devote full time or part time to the research and training program during the tenure of the Fellowship as per their proposal which the CHS will have accepted. If the supervisor considers a certain amount of teaching to be part of the training, such teaching and duties must be limited to no more than 10% of their time in order to not adversely affect the quality and quantity of the research training.
Stipend / Duration of Support
This program will offer one or more fellowships not exceeding total funding of $20,000.
Depending upon the number and quality of applications, funding for different amounts may be possible, as is the offering of more than one fellowship, within the allotted total budget stated above.
Fellowships will be offered for a one-year period to begin as early as April first. Fellowships must be initiated by December 31 of the year awarded.
Funds are to be used mainly for salary support and will normally be disbursed in two payments. A small amount can be devoted to project expenses.
It should be noted that allocation of the grant is conditional to the CHS having received from Shire funding confirmation in 2017 for the Fellowship Program.
General Conditions, Application Form and Deadlines
A letter of intent should be submitted to the Canadian Hemophilia Society by November 15, 2016. The CHS Peer Review Committee will invite a limited number of candidates to submit a more detailed proposal by January 9, 2017 in order to make a final selection. The letter of intent should have a maximum of two pages identifying the applying researcher and organization, and providing a summary description of the intended area of research.
All completed application forms and support documents must arrive at the National Office of the Canadian Hemophilia Society on or before January 9, 2017. If the CHS receives the application after the deadline date but it is postmarked on or before the deadline date, then it is considered to have been submitted on time. The name of the winner will be announced by March 2017.
Applications must be completed and submitted electronically to the Canadian Hemophilia Society and one (1) original paper copy, including signatures, must be sent to the National Office of the Canadian Hemophilia Society:
666 Sherbrooke Street West, Suite 301, Montreal, QC H3A 1E7
Please click on the following links for General Conditions and Application Form.
All applications are subjected to a rigorous peer review process and will be reviewed by an independent peer review committee composed of Canadian medical and healthcare professionals and a patient representative. Applications are critiqued on scientific merit and relevance to CHS research priorities and scored in terms of significance, approach, innovation, investigator, and environment/support. The committee will rank the applications and will make recommendations to the CHS Board of Directors on funding of the proposals. The final decisions regarding awards will be made by the CHS Board of Directors. No appeals will be considered.